|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 5/02 | |
| C12N 5/16 |
| (11) | Number of the document | 3055409 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14851841.8 |
| Date of filing the European patent application | 2014-10-10 | |
| (97) | Date of publication of the European application | 2016-08-17 |
| (45) | Date of publication and mention of the grant of the patent | 2018-04-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/059993 |
| Date | 2014-10-10 |
| (87) | Number | WO 2015/054554 |
| Date | 2015-04-16 |
| (30) | Number | Date | Country code |
| 201361889815 P | 2013-10-11 | US |
| (72) |
LAWRENCE, Shawn, US
KIM, Ann, US
JOHNSON, Amy, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | METABOLICALLY OPTIMIZED CELL CULTURE |
| METABOLICALLY OPTIMIZED CELL CULTURE |